GVS acquires 100% of the Shanghai Transfusion Technology Co., Ltd
GVS announced that it has entered into a binding agreement with Ningbo Fuji Medical Technology Co., Ltd., a company controlled by Shanghai Fosun Pharmaceutical (Group)
GVS announced that it has entered into a binding agreement with Ningbo Fuji Medical Technology Co., Ltd., a company controlled by Shanghai Fosun Pharmaceutical (Group)
GVS has acquired the 100% of the share capital of the Italian Group Haemotronic, a leading supplier of advanced filtration solutions for highly critical applications
First patent for ‘Infusion device with air intake’ registered by GVS
GVS Malaysia experts are always here for you! Contact us now if you have any questions!
You are currently at GVS Malaysia website. To visit the global website, click the button below.
You are currently at GVS Malaysia website. To visit the global website, click the button below.
We are always here for you! send us a mail now if you have any questions!